Bernstein W B, Scherokman B
Acta Neurol Scand. 1986 Jun;73(6):636-7. doi: 10.1111/j.1600-0404.1986.tb04612.x.
A patient with acquired immunodeficiency syndrome treated with prochlorperazine and droperidol developed neuroleptic malignant syndrome, characterized by akinetic mutism, resting tremor, cogwheel rigidity, and elevated serum creatine phosphokinase. An identical syndrome reappeared with subsequent administration of haloperidol. Neuroleptic malignant syndrome has not been previously reported in acquired immunodeficiency syndrome.
一名获得性免疫缺陷综合征患者在接受氯丙嗪和氟哌利多治疗后出现了抗精神病药恶性综合征，其特征为运动不能性缄默症、静止性震颤、齿轮样强直以及血清肌酸磷酸激酶升高。后续使用氟哌啶醇时，相同的综合征再次出现。抗精神病药恶性综合征在获得性免疫缺陷综合征中此前尚未有过报道。
